Meeting Will Resume on Wednesday, June 21, 2023 Believes FCM Has Made Deliberate Efforts to Prevent Quorum from Being Achieved MindMed Encourages Shareholders to. | June 15, 2023
FCM Believes MindMed Is Threatening to Violate NASDAQ Requirements Imperiling MindMed’s Listing and Future Liquidity for Shareholders Failure to Satisfy Quorum Requirement at Annual. | June 15, 2023
Mind Medicine Inc , , a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that its management team will a host an. | June 7, 2023
ISS Believes Company’s Director Nominees Represent an “Unusually Strong” Group of Current and Former Executives From Relevant Fields and Are Best Suited to Continue Overseeing. | June 5, 2023
Mind Medicine Inc , , a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company’s management. | June 1, 2023